SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
74.80    0.70 (0.94%)
Bid:
74.90
Ask:
74.94
Spread: 0.04 (0.053%)
Market Cap: £2.60b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

COVID-19 - Remuneration update

1 Apr 2020 07:00

RNS Number : 3133I
Taylor Wimpey PLC
01 April 2020
 

 

1 April 2020

Taylor Wimpey plc

 

Further update in response to COVID-19 - Application of Remuneration Policy in 2020

On 24 March 2020, Taylor Wimpey plc (the 'Company') announced a number of measures that were taken in response to the COVID-19 pandemic in the interest of the safety and wellbeing of our colleagues and customers. This included the temporary closure of all show homes, sales centres and construction sites.

In recognition of the impact of these measures on the Company's stakeholders and at the request of the Executive Directors, the Company's Remuneration Committee (the 'Committee') has carefully considered the proposed application of the Remuneration Policy in 2020.

The Committee has taken the decision to use its available discretion to amend the application of the Remuneration Policy for 2020 and we announce the following changes to the Executive Directors' remuneration for this year:

- The 2% annual salary increase due to come into effect on 1 April 2020 has been cancelled;

- The Executive Incentive Scheme (annual bonus) has been cancelled and there will be no cash bonus payable in respect of the Company's performance in 2020; and

- A voluntary 30% reduction in base salary and pension for the duration of the Government-imposed lockdown. In the event that the lockdown continues beyond 30 June 2020, the Remuneration Committee will review this particular matter again at that time.

The decision to take a reduction in base salary is supported by the whole Board and therefore the Non-Executive Directors will also take a 30% reduction in their fees for the same period of time. The objective of these changes is to conserve cash, with a particular focus on protecting the long term financial security of the business as a whole, for the benefit of all of the Company's stakeholders.

The Committee is not proposing any amendments to the Remuneration Policy which has been submitted to shareholders for approval at the Company's Annual General Meeting on 23 April 2020.

There will be full disclosure of the above measures in the 2020 Directors' Remuneration Report.

 

-Ends-

 

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885616

Alice Marsden, Group Company Secretary

Debbie Archibald, Investor Relations

 

Finsbury Tel: +44 (0) 20 7251 3801

Faeth Birch

Anjali Unnikrishnan

 

Notes to editors:

 

Taylor Wimpey plc is a customer-focused residential developer, operating at a local level from 24 regional businesses across the UK. We also have operations in Spain.

 

For further information, please visit the Group's website:

www.taylorwimpey.co.uk

 

Follow us on Twitter via @TaylorWimpeyplc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFZGFFNMGGGZM
Date   Source Headline
12th Jun 20267:00 amRNSDirector/PDMR Shareholding
9th Jun 20263:11 pmRNSDirector/PDMR Shareholding
9th Jun 20267:00 amRNSDirectorate change
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 202610:41 amRNSHolding(s) in Company
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20269:49 amRNSDirector/PDMR Shareholding
15th May 20261:32 pmRNSHolding(s) in Company
14th May 20267:00 amRNSTransaction in Own Shares
11th May 20264:10 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20263:30 pmRNSHolding(s) in Company
6th May 202611:05 amRNSHolding(s) in Company
5th May 202611:28 amRNSHolding(s) in Company
1st May 202611:53 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20264:34 pmRNSDirector/PDMR Shareholding
28th Apr 20264:23 pmRNSResult of AGM
28th Apr 20267:00 amRNSTrading Statement
23rd Apr 20269:25 amRNSTransaction in Own Shares
20th Apr 20268:41 amRNSDirector Declaration
16th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20263:42 pmRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20261:36 pmRNSTotal Voting Rights
30th Mar 20262:19 pmRNSHolding(s) in Company
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:22 pmRNSHolding(s) in Company
20th Mar 20263:37 pmRNSAnnual Financial Report and Notice of Meeting
19th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
10th Mar 20263:23 pmRNSDirector/PDMR Shareholding
6th Mar 202611:44 amRNSDirector/PDMR Shareholding
5th Mar 20267:01 amRNSShare Buyback Programme
5th Mar 20267:00 amRNSTAYLOR WIMPEY PLC FULL YEAR RESULTS
2nd Mar 202611:50 amRNSTotal Voting Rights
10th Feb 20263:19 pmRNSDirector/PDMR Shareholding
2nd Feb 20262:17 pmRNSTotal Voting Rights
22nd Jan 20263:11 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSTrading Statement
9th Jan 20262:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202612:02 pmRNSTotal Voting Rights
2nd Jan 202611:59 amRNSBlock listing Interim Review
2nd Jan 202611:54 amRNSBlock listing Interim Review
15th Dec 20254:17 pmRNSDirector/PDMR Shareholding
9th Dec 20254:21 pmRNSDirector/PDMR Shareholding
9th Dec 20254:18 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.